SLOUGH (dpa-AFX) - Consumer goods giant Reckitt Benckiser Group Plc or RB (RBGPF.PK, RB.L) announced the detailed proposed timetable for the demerger, following RB's announcement on July 28, 2014 that it was pursuing a demerger of the RB Pharmaceuticals or RBP business with a separate UK listing. The new demerged RBP company, to be called Indivior PLC (Indivior), would be UK domiciled and admitted to the premium listing segment of the Official List and traded on the London Stock Exchange's main market for listed securities.
RB's General Meeting to approve the demerger would be held on December 11, 2014. The demerger is likely to close and Indivior shares to begin trading on December 23, 2014.
RB's board considers that the demerger is in the best interests of both RB and Indivior and would lead to a stronger future for both RB and Indivior, with the boards of each company focused on developing their respective businesses into leaders in their specific sectors.
Copyright RTT News/dpa-AFX